Fund Houses Recommendations: ENREROHEALTH, VOLTAS, SUNTECK, GLENMARK, AUROPHARMA, KPITTECH

અમદાવાદ, 19 ઓગસ્ટઃ અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ દ્વારા પસંદગીના સ્ટોક્સમાં ખરીદી/ વેચાણ/ હોલ્ડ કરવા માટે સલાહ આપવામાં આવી છે તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Jefferies on Entero Health: Initiate Buy on Company, target price at Rs 1510 (Positive)

Jefferies on Voltas: Maintain Buy on Company, raise target price at Rs 1770 (Positive)

Nomura on Voltas: Maintain Buy on Company, raise target price at Rs 1857 (Positive)

UBS on Voltas: Maintain Buy on Company, raise target price at Rs 1960 (Positive)

Jefferies on Sunteck: Maintain Buy on Company, raise target price at Rs 690 (Positive)

Nuvama on Sunteck: Maintain Buy on Company, raise target price at Rs 690 (Positive)

MOSL on Glenmark Pharma: Upgrade to Buy on Company, raise target price at Rs 1850 (Positive)

HSBC on Auro Pharma: Maintain Buy on Company, target price at Rs 1625 (Positive)

HSBC on Shriram Fin: Maintain Buy on Company, raise target price at Rs 3600 (Positive)

JP Morgan on Persistent: Maintain Overweight on Company, raise target price at Rs 5300 (Positive)

JP Morgan on KPIT Tech: Maintain Neutral on Company, raise target price at Rs 1700 (Positive)

Nomura on Eclerx: Maintain Buy on Company, raise target price at Rs 3000 (Positive)

Emkay on Suprajit: Maintain Buy on Company, target price at Rs 725 (Positive)

UBS on Zomato: Maintain Buy on Company, target price at Rs 320 (Positive)

Bernstein on PayTM: Initiate Outperform on Company, target price at Rs 600 (Positive)

Systematix on Patanjali: Initiate Buy on Company, target price at Rs 2259 (Positive)

Nuvama on India Strategy: Expects consumer, private banks, insurance, IT to lead growth in Indian equity market. (Positive) 

Citi on India Strategy: Good ‘beats’ in Industrials and Discretionary, which saw strong growth (Positive)

JPMorgan on India Strategy: Continue to prefer longer-term capex story via Industrials, Real Estate and Financial sector. Upgrade Consumer Staples to overweight (Positive)

JPMorgan on India Strategy: Downgrade Auto to neutral (Neutral)

Bank of America India Strategy: Nifty earnings +3% YoY; ex-Financials/Energy +19% YoY (Neutral)

CLSA on Steel: India initiates anti-dumping investigation against imports from Vietnam (Neutral)

JP Morgan on LTTS: Maintain Overweight on Company, cut target price at Rs 5500 (Neutral)

JP Morgan on Cyient: Maintain Overweight on Company, cut target price at Rs 2100 (Neutral)

JP Morgan on Tata Tech: Maintain Underweight on Company, cut target price at Rs 750 (Neutral)

JP Morgan on Tata Elxsi: Maintain Underweight on Company, target price at Rs 5700 (Neutral) 

Kotak on Voltas: Maintain Sell on Company, target price at Rs 1100 (Neutral) 

CLSA on Voltas: Maintain Underperform on Company, target price at Rs 1310 (Neutral) 

ICICI on Mazdock: Maintain Sell on Company, target price at Rs 1165 (Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)